Sfoglia per RIVISTA
THE LANCET. RESPIRATORY MEDICINE
Collezione ASL Città di Torino
Items : 2
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. in The Lancet. Respiratory medicine / Lancet Respir Med. 2022 Aug;10(8):785-795. doi: 10.1016/S2213-2600(22)00100-X. Epub 2022 Jun 9.
2022
ASL Città di Torino
Ochoa-Azze R; Chang-Monteagudo A; Climent-Ruiz Y; Macías-Abraham C; Valenzuela-Silva C; de Los Ángeles García-García M; Jerez-Barceló Y; Triana-Marrero Y; Ruiz-Villegas L; Dairon Rodríguez-Prieto L; Guerra-Chaviano PP; Sánchez-Ramírez B; Hernández-García T; Orosa-Vázquez I; Díaz-Hernández M; Chiodo F; Calcagno A; Ghisetti V; Rodríguez-Acosta M; Noa-Romero E; Enríquez-Puertas J; Ortega-León D; Valdivia-Álvarez I; Delahanty-Fernández A; Palenzuela-Díaz A; Rodríguez-Noda L; González-Mugica R; Valdés-Balbín Y; García-Rivera D; et alii...
Extracorporeal membrane oxygenation for COVID-19 during first and second waves. in The Lancet. Respiratory medicine / Lancet Respir Med. 2021 Aug;9(8):e80-e81. doi: 10.1016/S2213-2600(21)00262-9. Epub 2021 Jun 16.
2021
ASL Città di Torino
Lorusso R; Belohlavek J; De Piero ME; Lo Coco V; Eksborg S; Broman LM;